CVS Health Corp. has agreed to pay $37.76 million to resolve a False Claims Act lawsuit alleging that its pharmacies ...
CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained ...
For a decade, CVS knew it was skirting rules meant to limit overprescribing but did nothing to stop, according to the ...
Aher holds an insulin pen next to his father, Lual, in their home in Ariath, Aweil North, South Sudan. 2025 © Isaac Buay ...
The success of semaglutide and tirzepatide is evident in their 2024 sales volumes and revenues, creating a clearer picture of ...
Despite its small base, rapid growth in smart insulin administration, connected devices, patient-centric care, and home-based ...
Dolfin is a well-established, diversified distributor with broad reach across healthcare, hospitals, emergency services, and consumers provides strong potential for VIVI products to gain ...
I don’t feel like I’m dragging anymore.” So far, he has experienced no side effects and plans to continue microdosing as long ...
While Ozempic has gained global popularity for treating type-2 diabetes and consequently triggering weight loss, many are now ...
California lawmakers and Gov. Gavin Newsom approved new laws impacting pet owners, landlords, school bathrooms and more.
Oprah Daily on MSN
A New Form of GLP-1s Could Revolutionize Weight-Loss Treatment (Again)—And It’ll Be Available in 2026
They’re definitely easier and more affordable than injectables, but do they work as well? Here’s what you need to know.
A doctor meets with a drug addict at his hospital in Srinagar. In the conversation between the two reproduced below, some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results